Search | Browse by Day | Author Index

Author Index: Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Zabel, M.
  • PERFORMANCE OF HEAD CIRCUMFERENCE PERCENTILE CUTOFFS
    • Zaric, G. S.
  • COST EFFECTIVENESS OF SCREENING FOR ACUTE HIV AND HCV INFECTION IN INJECTION DRUG USERS
  • MODELLING A PAY-FOR-PERFORMANCE RISK SHARING AGREEMENT
  • STEREOTACTIC BODY RADIOTHERAPY VERSUS SURGERY FOR MEDICALLY OPERABLE STAGE I NON-SMALL CELL LUNG CANCER: A MARKOV MODEL BASED DECISION ANALYSIS
  • MICROSOFT EXCEL: BASIC SKILLS FOR EFFICIENCY AND MODELING
  • REDUCING PATIENT WAIT TIMES FOR RADIATION THERAPY AND IMPROVING THE RADIATION TREATMENT PLANNING EFFICIENCY WITH THE AID OF A DISCRETE-EVENT SIMULATION MODEL
  • OPTIMIZING THE NUMBER OF NEONATAL INTENSIVE CARE UNIT BEDS IN BRITISH COLUMBIA
  • MICROSOFT EXCEL: ADVANCED SKILLS FOR EFFICIENCY AND MODELING
    • Zasadil, S.
  • PREDICTING HOSPITAL READMISSIONS BEFORE THE INITIAL ADMISSION
    • Zefeng, Z.
  • INPATIENT COSTS OF CORONARY HEART DISEASE AMONG ADULTS AGED 18-64 YEARS
    • Zeliadt, S. B.
  • DO MEN SCHEDULING A PROSTATE BIOPSY BENEFIT FROM INFORMATION ABOUT POTENTIAL TREATMENT OPTIONS?
    • Zenitani, S.
  • DEVELOPMENT OF DECISION SUPPORT SYSTEM FOR SUBJECTS TESTED POSITIVE FOR CANCER
    • Zhang, J.
  • MEASURING THE BENEFIT OF PSA SCREENING FROM THE PATIENT AND SOCIETAL PERSPECTIVES
    • Zhang, L.
  • APPLICATION OF ESTIMATION AND PROJECTION PACKAGE TO THE CONTEXT OF AUSTRALIA'S HIV EPIDEMIC
    • Zhang, Y.
  • A GENERIC MULTI-STATE SIMULATION MODEL FOR ASSESSING DIAGNOSTIC TESTS
    • Zikmund-Fisher, B. J.
  • IMPRECISE DEFINITIONS OF “PRECISE”: PREFERENCES FOR PRECISION DEPEND ON CONTEXT
  • TO HAVE OR NOT TO HAVE PSA TEST? IS THE DECISION AFFECTED BY WHETHER INFORMATION IS PRESENTED SEQUENTIALLY VS. ALL-AT-ONCE?
  • COOL, BUT COUNTERPRODUCTIVE: INTERACTIVE, WEB-BASED RISK COMMUNICATIONS CAN BACKFIRE
  • INFORMATION OVERLOAD IN BREAST CANCER DECISION MAKING: WHEN TWO CHOICES ARE TOO MANY
  • COLOSTOMY IS BETTER THAN DEATH, BUT A 4% CHANCE OF DEATH MIGHT BE BETTER THAN A 4% CHANCE OF COLOSTOMY: WHY PEOPLE MAKE CHOICES SEEMINGLY AT ODDS WITH THEIR STATED PREFERENCES
    • Zimhony, O.
  • POORLY PERCEIVED PERSONAL ACCOUNTABILITY: INFECTION CONTROL'S MISSING LINK?
    • Zimmerman, R. K.
  • COST-EFFECTIVENESS OF COMBINED INFLUENZA AND PNEUMOCOCCAL VACCINATION: IS IT THE RIGHT TIME?
    • Zipperer, C.
  • DO MEN SCHEDULING A PROSTATE BIOPSY BENEFIT FROM INFORMATION ABOUT POTENTIAL TREATMENT OPTIONS?
    • Zivkovic Gojovic, M.
  • IS A MASS IMMUNIZATION PROGRAM FOR PANDEMIC (H1N1) 2009 GOOD VALUE FOR MONEY? EVIDENCE FROM THE CANADIAN EXPERIENCE
    • Zlatnik, M.
  • COST EFFECTIVENESS OF ANTENATAL STEROIDS IN LATE PRETERM PREGNANCIES
    • Zou, D.
  • COST-EFFECTIVENESS IN CANADA OF RITUXIMAB FOR PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC LEUKEMIA
    • Zuckerman, D.
  • AN INNOVATIVE APPROACH TO ADDRESSING DIAGNOSTIC ERRORS AND SHARED DECISION MAKING
    • Zwaan, L.
  • DO DIAGNOSTIC REASONING FAULTS ALWAYS RESULT IN DIAGNOSTIC ERRORS OR PATIENT HARM?
  • HOW ARE EVIDENCE-BASED DECISIONS RULES APPLIED TO PATIENTS WITH A SUSPICION ON PULMONARY EMBOLISM?
  • DO DIAGNOSTIC REASONING FAULTS ALWAYS RESULT IN DIAGNOSTIC ERRORS OR PATIENT HARM?
  • HOW ARE EVIDENCE-BASED DECISIONS RULES APPLIED TO PATIENTS WITH A SUSPICION ON PULMONARY EMBOLISM?
    • Zwinderman, K. H.
  • CORRECTING FOR PARTIAL VERIFICATION BIAS: A COMPARISON OF METHODS
    • A B C D E F G H I J K L M N O P Q R S T U V W X Y Z